Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a g...
Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a global scale
About this item
Full title
Author / Creator
Publisher
Bangladesh: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Bangladesh: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that increase the risk of cardiovascular diseases (CVD). Patients with inflammatory bowel disease (IBD) may be at higher risk of developing MetS due to chronic inflammation, altered adipokine profiles, and the effects of corticosteroid treatment. However, the prevalence of MetS in IB...
Alternative Titles
Full title
Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a global scale
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_688bac8b9be9404cba4ff08aac4ab8d0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_688bac8b9be9404cba4ff08aac4ab8d0
Other Identifiers
ISSN
2072-1315,1606-0997
E-ISSN
2072-1315
DOI
10.1186/s41043-025-00860-z
